Global Type 2 Diabetes Market Size study & Forecast, by Drug Class (Dipeptidyl Peptidase-4, Inhibitors, Glucagon-Like Peptide Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas & Other Insulin Secretagogues, Biguanides, Sodium Glucose Cotransport 2 Inhibitors), by Application (Glycaemic Control, Cardiovascular Safety, Hypoglycaemia Avoidance , Others) and Regional Analysis, 2023-2030
Global Type 2 Diabetes Market is valued approximately at USD 32.32 billion in 2022 and is anticipated to grow with a compounded annual growth rate of more than 8.4% over the forecast period 2023-2030. Type 2 Diabetes, also known as adult-onset diabetes or non-insulin-dependent diabetes is a chronic metabolic disorder characterized by high blood sugar levels. It is the most common form of diabetes accounting for approximately 90% to 95% of all diagnosed cases. Unlike type one diabetes, which is an autoimmune condition where the body fails to produce insulin type two diabetes is characterized by insulin resistance and inadequate insulin production. Increasing number of diabetic patients and growing geriatric population elucidate as the growth drivers of this market during the forecast period.
According to the World Health Organization, diabetes may afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. According to the World Bank Group in 2022, the world old population was 727 million in 2020, and it is predicted to rise over the next three decades, reaching 1.5 billion in 2050. However, lack of awareness of disease and limited treatment options availability may hamper the growth space of this market. Furthermore, emerging pharma sector and increasing prevalence of type 2 diabetes anticipated to elevate the growth of the Global Type 2 Diabetes Market.
The key regions considered for the Global Type 2 Diabetes Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the type 2 diabetes market. The region's market growth is driven by the increasing prevalence of diabetes, with over 29 million individuals affected, expected to rise to 32 million by 2025. Notably, the United States alone had more than 25 million diabetic patients in 2019. The expansion of the healthcare sector, favorable government regulations, and a growing number of initiatives and favorable reimbursement policies contribute to the overall growth of the type 2 diabetes market in North America. Europe is anticipated to exhibit the highest growth rate among regions. Within Europe, the type 2 diabetes market is primarily dominated by the United Kingdom. The increasing number of patients with type 2 diabetes is a key driver for market growth in the region. Factors such as escalating research and development activities and the rising prevalence of obesity contribute to the demand for type 2 diabetes drugs. Furthermore, enhanced supply chain management presents favorable opportunities for the expansion of the type 2 diabetes market in Europe.
Major market player included in this report are:
Amgen Inc.
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Daiichi Sankyo Co. Ltd
Eli Lilly and Co.
Merck & Co. Inc
Novo Nordisk AS
Sanofi SA
Takeda Pharmaceutical Co. Ltd
Novartis AG
Recent Developments in the Market:
In October 2022, Glenmark Pharmaceuticals introduced a novel medication called Zita D, intended for the treatment of patients with type 2 diabetes, particularly those who also have a comorbid condition.
In March 2019, Novo Nordisk announced its plans to invest approximately USD 98 million in the expansion and advancement of its insulin medicine manufacturing facility located in Denmark. The completion of this project is anticipated to occur by the conclusion of 2020.
Global Type 2 Diabetes Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Drug Class, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
Dipeptidyl Peptidase-4 Inhibitors
Glucagon-Like Peptide Receptor Agonists
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Sulfonylureas & Other Insulin Secretagogues
Biguanides
Sodium Glucose Cotransport 2 Inhibitors
By Application:
Glycaemic Control
Cardiovascular Safety
Hypoglycaemia Avoidance
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
According to the World Health Organization, diabetes may afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. According to the World Bank Group in 2022, the world old population was 727 million in 2020, and it is predicted to rise over the next three decades, reaching 1.5 billion in 2050. However, lack of awareness of disease and limited treatment options availability may hamper the growth space of this market. Furthermore, emerging pharma sector and increasing prevalence of type 2 diabetes anticipated to elevate the growth of the Global Type 2 Diabetes Market.
The key regions considered for the Global Type 2 Diabetes Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the type 2 diabetes market. The region's market growth is driven by the increasing prevalence of diabetes, with over 29 million individuals affected, expected to rise to 32 million by 2025. Notably, the United States alone had more than 25 million diabetic patients in 2019. The expansion of the healthcare sector, favorable government regulations, and a growing number of initiatives and favorable reimbursement policies contribute to the overall growth of the type 2 diabetes market in North America. Europe is anticipated to exhibit the highest growth rate among regions. Within Europe, the type 2 diabetes market is primarily dominated by the United Kingdom. The increasing number of patients with type 2 diabetes is a key driver for market growth in the region. Factors such as escalating research and development activities and the rising prevalence of obesity contribute to the demand for type 2 diabetes drugs. Furthermore, enhanced supply chain management presents favorable opportunities for the expansion of the type 2 diabetes market in Europe.
Major market player included in this report are:
Amgen Inc.
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Daiichi Sankyo Co. Ltd
Eli Lilly and Co.
Merck & Co. Inc
Novo Nordisk AS
Sanofi SA
Takeda Pharmaceutical Co. Ltd
Novartis AG
Recent Developments in the Market:
In October 2022, Glenmark Pharmaceuticals introduced a novel medication called Zita D, intended for the treatment of patients with type 2 diabetes, particularly those who also have a comorbid condition.
In March 2019, Novo Nordisk announced its plans to invest approximately USD 98 million in the expansion and advancement of its insulin medicine manufacturing facility located in Denmark. The completion of this project is anticipated to occur by the conclusion of 2020.
Global Type 2 Diabetes Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Drug Class, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
Dipeptidyl Peptidase-4 Inhibitors
Glucagon-Like Peptide Receptor Agonists
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Sulfonylureas & Other Insulin Secretagogues
Biguanides
Sodium Glucose Cotransport 2 Inhibitors
By Application:
Glycaemic Control
Cardiovascular Safety
Hypoglycaemia Avoidance
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Type 2 Diabetes Market, by region, 2020-2030 (USD Billion)
1.2.2. Type 2 Diabetes Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Type 2 Diabetes Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL TYPE 2 DIABETES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL TYPE 2 DIABETES MARKET DYNAMICS
3.1. Type 2 Diabetes Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Number of Diabetes Patients
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Lack of Awareness of Disease
3.1.2.2. Limited Treatment Options Available
3.1.3. Market Opportunities
3.1.3.1. Emerging Pharma Sector
3.1.3.2. Increasing Prevalence of Type 2 Diabetes
CHAPTER 4. GLOBAL TYPE 2 DIABETES MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL TYPE 2 DIABETES MARKET, BY DRUG CLASS
5.1. Market Snapshot
5.2. Global Type 2 Diabetes Market by Drug Class, Performance - Potential Analysis
5.3. Global Type 2 Diabetes Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Type 2 Diabetes Market, Sub Segment Analysis
5.4.1. Dipeptidyl Peptidase-4 Inhibitors
5.4.2. Glucagon-Like Peptide
5.4.3. Receptor Agonists
5.4.4. Thiazolidinediones
5.4.5. Alpha-Glucosidase Inhibitors
5.4.6. Sulfonylureas and other Secretagogues
5.4.7. Biguanides
5.4.8. Sodium Glucose Cotransport 2 Inhibitors
CHAPTER 6. GLOBAL TYPE 2 DIABETES MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Type 2 Diabetes Market by Application, Performance - Potential Analysis
6.3. Global Type 2 Diabetes Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Type 2 Diabetes Market, Sub Segment Analysis
6.4.1. Glycaemic Control
6.4.2. Cardiovascular Safety
6.4.3. Hypoglycaemia Avoidance
6.4.4. Others
CHAPTER 7. GLOBAL TYPE 2 DIABETES MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Type 2 Diabetes Market, Regional Market Snapshot
7.4. North America Type 2 Diabetes Market
7.4.1. U.S. Type 2 Diabetes Market
7.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Type 2 Diabetes Market
7.5. Europe Type 2 Diabetes Market Snapshot
7.5.1. U.K. Type 2 Diabetes Market
7.5.2. Germany Type 2 Diabetes Market
7.5.3. France Type 2 Diabetes Market
7.5.4. Spain Type 2 Diabetes Market
7.5.5. Italy Type 2 Diabetes Market
7.5.6. Rest of Europe Type 2 Diabetes Market
7.6. Asia-Pacific Type 2 Diabetes Market Snapshot
7.6.1. China Type 2 Diabetes Market
7.6.2. India Type 2 Diabetes Market
7.6.3. Japan Type 2 Diabetes Market
7.6.4. Australia Type 2 Diabetes Market
7.6.5. South Korea Type 2 Diabetes Market
7.6.6. Rest of Asia Pacific Type 2 Diabetes Market
7.7. Latin America Type 2 Diabetes Market Snapshot
7.7.1. Brazil Type 2 Diabetes Market
7.7.2. Mexico Type 2 Diabetes Market
7.8. Middle East & Africa Type 2 Diabetes Market
7.8.1. Saudi Arabia Type 2 Diabetes Market
7.8.2. South Africa Type 2 Diabetes Market
7.8.3. Rest of Middle East & Africa Type 2 Diabetes Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Amgen Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. AstraZeneca PLC
8.3.3. Boehringer Ingelheim International GmbH
8.3.4. Daiichi Sankyo Co. Ltd
8.3.5. Eli Lilly and Co.
8.3.6. Merck & Co. Inc
8.3.7. Novo Nordisk AS
8.3.8. Sanofi SA
8.3.9. Takeda Pharmaceutical Co. Ltd
8.3.10. Novartis AG
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Type 2 Diabetes Market, by region, 2020-2030 (USD Billion)
1.2.2. Type 2 Diabetes Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Type 2 Diabetes Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL TYPE 2 DIABETES MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL TYPE 2 DIABETES MARKET DYNAMICS
3.1. Type 2 Diabetes Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing Number of Diabetes Patients
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Lack of Awareness of Disease
3.1.2.2. Limited Treatment Options Available
3.1.3. Market Opportunities
3.1.3.1. Emerging Pharma Sector
3.1.3.2. Increasing Prevalence of Type 2 Diabetes
CHAPTER 4. GLOBAL TYPE 2 DIABETES MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL TYPE 2 DIABETES MARKET, BY DRUG CLASS
5.1. Market Snapshot
5.2. Global Type 2 Diabetes Market by Drug Class, Performance - Potential Analysis
5.3. Global Type 2 Diabetes Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Type 2 Diabetes Market, Sub Segment Analysis
5.4.1. Dipeptidyl Peptidase-4 Inhibitors
5.4.2. Glucagon-Like Peptide
5.4.3. Receptor Agonists
5.4.4. Thiazolidinediones
5.4.5. Alpha-Glucosidase Inhibitors
5.4.6. Sulfonylureas and other Secretagogues
5.4.7. Biguanides
5.4.8. Sodium Glucose Cotransport 2 Inhibitors
CHAPTER 6. GLOBAL TYPE 2 DIABETES MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Type 2 Diabetes Market by Application, Performance - Potential Analysis
6.3. Global Type 2 Diabetes Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Type 2 Diabetes Market, Sub Segment Analysis
6.4.1. Glycaemic Control
6.4.2. Cardiovascular Safety
6.4.3. Hypoglycaemia Avoidance
6.4.4. Others
CHAPTER 7. GLOBAL TYPE 2 DIABETES MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Type 2 Diabetes Market, Regional Market Snapshot
7.4. North America Type 2 Diabetes Market
7.4.1. U.S. Type 2 Diabetes Market
7.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Type 2 Diabetes Market
7.5. Europe Type 2 Diabetes Market Snapshot
7.5.1. U.K. Type 2 Diabetes Market
7.5.2. Germany Type 2 Diabetes Market
7.5.3. France Type 2 Diabetes Market
7.5.4. Spain Type 2 Diabetes Market
7.5.5. Italy Type 2 Diabetes Market
7.5.6. Rest of Europe Type 2 Diabetes Market
7.6. Asia-Pacific Type 2 Diabetes Market Snapshot
7.6.1. China Type 2 Diabetes Market
7.6.2. India Type 2 Diabetes Market
7.6.3. Japan Type 2 Diabetes Market
7.6.4. Australia Type 2 Diabetes Market
7.6.5. South Korea Type 2 Diabetes Market
7.6.6. Rest of Asia Pacific Type 2 Diabetes Market
7.7. Latin America Type 2 Diabetes Market Snapshot
7.7.1. Brazil Type 2 Diabetes Market
7.7.2. Mexico Type 2 Diabetes Market
7.8. Middle East & Africa Type 2 Diabetes Market
7.8.1. Saudi Arabia Type 2 Diabetes Market
7.8.2. South Africa Type 2 Diabetes Market
7.8.3. Rest of Middle East & Africa Type 2 Diabetes Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Amgen Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. AstraZeneca PLC
8.3.3. Boehringer Ingelheim International GmbH
8.3.4. Daiichi Sankyo Co. Ltd
8.3.5. Eli Lilly and Co.
8.3.6. Merck & Co. Inc
8.3.7. Novo Nordisk AS
8.3.8. Sanofi SA
8.3.9. Takeda Pharmaceutical Co. Ltd
8.3.10. Novartis AG
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Type 2 Diabetes Market, report scope
TABLE 2. Global Type 2 Diabetes Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Type 2 Diabetes Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 4. Global Type 2 Diabetes Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Type 2 Diabetes Market
TABLE 70. List of primary sources, used in the study of global Type 2 Diabetes Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Type 2 Diabetes Market, report scope
TABLE 2. Global Type 2 Diabetes Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Type 2 Diabetes Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 4. Global Type 2 Diabetes Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Type 2 Diabetes Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Type 2 Diabetes Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Type 2 Diabetes Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Type 2 Diabetes Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Type 2 Diabetes Market
TABLE 70. List of primary sources, used in the study of global Type 2 Diabetes Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Type 2 Diabetes Market, research methodology
FIG 2. Global Type 2 Diabetes Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Type 2 Diabetes Market, key trends 2022
FIG 5. Global Type 2 Diabetes Market, growth prospects 2023-2030
FIG 6. Global Type 2 Diabetes Market, porters 5 force model
FIG 7. Global Type 2 Diabetes Market, pest analysis
FIG 8. Global Type 2 Diabetes Market, value chain analysis
FIG 9. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Type 2 Diabetes Market, regional snapshot 2020 & 2030
FIG 15. North America Type 2 Diabetes Market 2020 & 2030 (USD Billion)
FIG 16. Europe Type 2 Diabetes Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Type 2 Diabetes Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Type 2 Diabetes Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Type 2 Diabetes Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Type 2 Diabetes Market, research methodology
FIG 2. Global Type 2 Diabetes Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Type 2 Diabetes Market, key trends 2022
FIG 5. Global Type 2 Diabetes Market, growth prospects 2023-2030
FIG 6. Global Type 2 Diabetes Market, porters 5 force model
FIG 7. Global Type 2 Diabetes Market, pest analysis
FIG 8. Global Type 2 Diabetes Market, value chain analysis
FIG 9. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Type 2 Diabetes Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Type 2 Diabetes Market, regional snapshot 2020 & 2030
FIG 15. North America Type 2 Diabetes Market 2020 & 2030 (USD Billion)
FIG 16. Europe Type 2 Diabetes Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Type 2 Diabetes Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Type 2 Diabetes Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Type 2 Diabetes Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
